Lowest Price Guaranteed From USD 4,799
Published
May 2023
Pages
191
View Count
8852
Example Insights
 |
 |
 |
 |
 |
 |
 |
Report Description
The global conjugation and labeling services market is estimated to be worth $0.9 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 10.2% during the forecast period. Conjugation is the process of formation of a single, stable hybrid, wherein one of the entities is a molecule, such as protein, antibody, peptide and small molecule. These molecules can be conjugated with various modalities, such as haptens, enzymes, isotopes, fluorescent tags, carrier proteins, polymers, particle conjugates and photoreactive molecules. Bioconjugation is a subset of conjugation where one of the entity is a biomolecule, such as protein or an antibody. The synergistic combination of the conjugates and biomolecules confer desired functions, which otherwise are difficult to achieve with individual counterparts. These functionalities offer increased membrane permeability, target specificity, circulation time and enhanced pharmacokinetic properties. It is interesting to highlight that when the modification with conjugates lead to detection (direct / indirect) in bioimaging and immunoassays, bioconjugation is also referred to as biomolecule labeling. Presently, industry stakeholders employ various labeling approaches (fluorescent labeling and isotopic labeling) for protein profiling in order to quantify the compounds, and monitor and visualize the biological processes. Over the last couple of years, the pharmaceutical industry has also witnessed the utility of these complex entities across several application areas, such as development of conjugated drug therapeutics, drug delivery systems, disease diagnosis, invention of diagnostic tools, and high-throughput screening. Presently, a number of players across the globe are actively engaged in providing efficient antibody conjugation services for research purposes. Further, given the rising demand for conjugated biomolecules in the field of research and development, the conjugation and labeling services market is anticipated to witness substantial growth in the foreseen future.
The Conjugation and Labeling Services Market: Focus on Protein Labeling, Peptide Labeling, Small Molecule Conjugation and Antibody Conjugation: Distribution by Type of Molecule Supported (Proteins, Peptides, Small Molecules, Antibodies and Other Molecules), Type of Molecular Conjugate / Label (Polymers, Haptens, Enzymes, Fluorescent Tags, Bead Coupling / Particle Conjugates, Quantum Dots, Isotopes and Other Molecular Conjugates / Labels), and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape, market size and the likely future potential of the conjugation and labeling services market, during the forecast period. Further, it highlights the efforts of several stakeholders engaged in this rapidly emerging domain of the pharmaceutical industry. Key inclusions of the report are briefly discussed below.
A number of drug developers and research institutes currently lack the technical expertise related to bioconjugation chemistries, along with limited in-house capabilities and scarcity of advanced bioconjugation technologies, which are essential to carry out the process of conjugation. In order to leverage the relevant experience and expertise of service providers, several organizations prefer to outsource their antibody conjugation services and protein labeling operations. The service providers tend to be equipped with established methodologies, along with a wide range of reagent systems and conjugates required for the chemical modification of different biomolecules. These factors together will be responsible for market growth through increased outsourcing of protein labeling, antibody labeling and antibody conjugation services to the CROs.
The current market landscape features the presence of over 170 companies providing antibody conjugation services and 120 companies providing service for protein labeling, spread across the globe. Overall, the market seems to be well-fragmented, featuring the presence of very large, large, mid-sized and small companies, which have the required expertise to offer bioconjugation services across different types of biomolecules, such as proteins, antibodies, peptides and small molecules. It is worth mentioning that 78% of the service providers offer antibody conjugation with haptens; notable examples (which have also been captured in this report) include AAT Bioquest, Abzena, Fina Biosolutions, Life Tein, ProSci, Synaptic Systems and ViroGen.
Custom antibody conjugation for research purposes is the most sought service in this market. Some of the antibody conjugation services offered by the companies include conjugation with HRP conjugation, Biotin Conjugation and Fluorescent labeling services. Antibody labeling, which is also known as antibody conjugation, involves conjugating a tag to an antibody. In this report, we have captured all the antibody conjugation services that are relevant to research / diagnostic applications.
Fluorescent tags are widely employed in the field of proteomics in order to detect the location of protein and quantity of the protein. These also lead to identification of conformational changes during protein complex formation and tracking the biological processes. Some of the companies also offer tagging of fluorescent probes with antibodies and peptides for research purposes.
Over the past few years, there has been a steady increase in the companies offering protein labeling, peptide labeling, small molecule conjugation and antibody conjugation services. Of these, majority of the bioconjugation service providers are based in North America.
Various stakeholders have been making consolidated efforts to forge alliance with other industry / non-industry players. It is worth highlighting that, since 2018, over 70 strategic partnerships have been inked, indicating that service providers are actively upgrading their conjugation related capabilities and accommodating the current and anticipated demand for bioconjugates. The field is continuously evolving; stakeholders are actively participating in events (webinars / conferences / seminars / meetings / symposiums / summits) related to bioconjugation and labeling of biomolecules. These events are likely to provide the necessary platform for companies to present their ideas, innovative bioconjugation methodologies / techniques and discuss various applications of bioconjugates to a wider audience. Given the inclination towards cutting-edge technologies, along with innovative approaches to tailor the biomolecules, we believe that the conjugation and labeling services market is likely to evolve at a rapid pace, during the forecast period 2023-2035.
Several recent developments have taken place in the field of conjugate and labelling service market. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.
The study presents an in-depth analysis of the various firms / organizations that are engaged in this domain, across different segments as defined in the below table:
| Key Report Attributes | Details | |
|
Forecast Period |
|
|
|
Type of Molecule Supported |
|
|
|
Type of Molecular Conjugate / Label |
|
|
|
Key Geographical Regions |
|
|
|
Key Companies Profiled |
|
|
|
Customization Scope |
|
|
|
PowerPoint Presentation (Complimentary) |
|
|
|
Excel Data Packs (Complimentary) |
|
|
The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report features:
One of the key objectives of the report was to evaluate the current opportunity and future potential associated with conjugation and labeling services market, over the forecast period. We have provided informed estimates of the likely evolution of the market in the short to mid-term and long term, for the period 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of molecule supported (proteins, peptides, small molecules, antibodies and other molecules), type of molecular conjugate / label (polymers, haptens, enzymes, fluorescent tags, bead coupling / particle conjugates, quantum dots, isotopes and other molecular conjugates / labels), and key geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the market growth.
The opinions and insights presented in the report were influenced by discussions held with stakeholders in this domain. The report features detailed transcripts of interviews held with the following industry stakeholders:
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Contents
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Biomolecule Conjugation and Labeling
3.3. Types of Biomolecular Conjugates and Labels
3.4. Applications of Conjugated and Labeled Biomolecules
3.5. Concluding Remarks
4. CONJUGATION AND LABELING SERVICE PROVIDERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Conjugation and Labeling Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.2.5. Analysis by Type of Molecule(s) Conjugated / Labeled
4.2.6. Analysis by Type of Molecular Conjugate(s) / Label(s) Used
4.2.6.1. Analysis by Type of Enzyme(s) Used
4.2.6.2. Analysis by Type of Hapten(s) Used
4.2.7. Analysis by Conjugation Service(s) Offered
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions / Key Parameters
5.3. Methodology
5.4. Company Competitiveness Analysis
5.4.1. Conjugation and Labeling Service Providers based in North America
5.4.2. Conjugation and Labeling Service Providers based in Europe
5.4.3. Conjugation and Labeling Service Providers based in Asia-Pacific
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. AltaBioscience
6.2.1. Company Overview
6.2.2. Recent Developments and Future Outlook
6.3. Bachem
6.3.1. Company Overview
6.3.2. Recent Developments and Future Outlook
6.4. Bio-Synthesis
6.4.1. Company Overview
6.4.2. Recent Developments and Future Outlook
6.5. Cayman Chemical
6.5.1. Company Overview
6.5.2. Recent Developments and Future Outlook
6.6. CliniSciences
6.6.1. Company Overview
6.6.2. Recent Developments and Future Outlook
6.7. Eurogentec
6.7.1. Company Overview
6.7.2. Recent Developments and Future Outlook
6.8. GBI (formerly known as Goodwin Biotechnology)
6.8.1. Company Overview
6.8.2. Recent Developments and Future Outlook
6.9. Mimotopes
6.9.1. Company Overview
6.9.2. Recent Developments and Future Outlook
6.10. Peptide Institute
6.10.1. Company Overview
6.10.2. Recent Developments and Future Outlook
6.11. piCHEM
6.11.1. Company Overview
6.11.2. Recent Developments and Future Outlook
7. PARTNERSHIPS AND COLLABORATIONS
7.1. Chapter Overview
7.2. Partnership Models
7.3. Conjugation and Labeling Services: Partnerships and Collaborations
7.3.1. Analysis by Year of Partnership
7.3.2. Analysis by Type of Partnership
7.3.3. Analysis by Year and Type of Partnership
7.3.4. Analysis by Type of Partner
7.3.5. Analysis by Year of Partnership and Type of Partner
7.3.6. Analysis by Type of Partnership and Type of Partner
7.3.7. Analysis by Location of Headquarters of Partner
7.3.8. Analysis by Type of Partnership and Location of Headquarters of Partner
7.3.9. Most Active Players: Analysis by Number of Partnerships
7.3.10. Analysis by Geography
7.3.10.1. Intercontinental and Intracontinental Deals
7.3.10.2. Local and International Deals
8. GLOBAL EVENT ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Conjugation and Labeling Services: Global Event Analysis
8.3.1. Analysis by Year of Event
8.3.2. Analysis by Event Platform
8.3.3. Analysis by Type of Event
8.3.4. Analysis by Year and Type of Event
8.3.5. Analysis by Geography
8.3.6. Word Cloud Analysis: Evolutionary Trends in Event Agenda / Key Focus Area
8.3.7. Most Active Organizers: Analysis by Number of Events
8.4. Global Events: Speaker Analysis
8.4.1. Most Active Industry Players: Analysis by Number of Speakers
8.4.2. Most Active Non-Industry Players: Analysis by Number of Speakers
8.4.3. Analysis by Seniority Level of Event Speakers
8.5. Geographical Mapping of Upcoming Events
8.6. Concluding Remarks
9. SWOT ANALYSIS
9.1. Chapter Overview
9.2. Conjugation and Labeling Services: SWOT Analysis
9.2.1. Comparison of SWOT Factors
10. MARKET FORECAST AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Key Assumptions and Forecast Methodology
10.3. Global Conjugation and Labeling Services Market, 2023-2035
10.4. Conjugation and Labeling Services Market: Analysis by Type of Molecule
10.4.1. Conjugation and Labeling Services Market for Proteins, 2023-2035
10.4.2. Conjugation and Labeling Services Market for Antibodies, 2023-2035
10.4.3. Conjugation and Labeling Services Market for Peptides, 2023-2035
10.4.4. Conjugation and Labeling Services Market for Small Molecules, 2023-2035
10.4.5. Conjugation and Labeling Services Market for Other Molecules, 2023-2035
10.5. Conjugation and Labeling Services Market: Analysis by Type of Molecular Conjugate / Label
10.5.1. Conjugation and Labeling Services Market for Polymers, 2023-2035
10.5.2. Conjugation and Labeling Services Market for Haptens, 2023-2035
10.5.3. Conjugation and Labeling Services Market for Enzymes, 2023-2035
10.5.4. Conjugation and Labeling Services Market for Fluorescent Tags, 2023-2035
10.5.5. Conjugation and Labeling Services Market for Bead Coupling / Particle Conjugates, 2023-2035
10.5.6. Conjugation and Labeling Services Market for Quantum Dots, 2023-2035
10.5.7. Conjugation and Labeling Services Market for Isotopes, 2023-2035
10.5.8. Conjugation and Labeling Services Market for Other Molecular Conjugates / Labels, 2023-2035
10.6. Conjugation and Labeling Services Market: Analysis by Key Geographical Regions
10.6.1. Conjugation and Labeling Services Market in North America, 2023-2035
10.6.2. Conjugation and Labeling Services Market in Europe, 2023-2035
10.6.3. Conjugation and Labeling Services Market in Asia-Pacific, 2023-2035
10.6.4. Conjugation and Labeling Services Market in Middle East and North Africa, 2023-2035
10.6.5. Conjugation and Labeling Services Market in Latin America, 2023-2035
11. CONCLUSION
12. EXECUTIVE INSIGHTS
13. APPENDIX 1: TABULATED DATA
14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Partnerships and Collaborations
Figure 2.3 Executive Summary: Global Event Analysis
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Advantages of Biomolecule Conjugation and Labeling
Figure 3.2 Types of Biomolecular Conjugates and Labels
Figure 4.1 Conjugation and Labeling Service Providers: Distribution by Year of Establishment
Figure 4.2 Conjugation and Labeling Service Providers: Distribution by Company Size
Figure 4.3 Conjugation and Labeling Service Providers: Distribution by Location of Headquarters
Figure 4.4 Conjugation and Labeling Service Providers: Distribution by Company Size and Location of Headquarters
Figure 4.5 Conjugation and Labeling Service Providers: Distribution by Type of Molecule(s) Conjugated / Labeled
Figure 4.6 Conjugation and Labeling Service Providers: Distribution by Type of Molecular Conjugate(s) / Label(s) Used
Figure 4.7 Conjugation and Labeling Service Providers: Distribution by Type of Enzyme(s) Used
Figure 4.8 Conjugation and Labeling Service Providers: Distribution by Type of Hapten(s)Used
Figure 4.9 Conjugation and Labeling Service Providers: Distribution by Conjugation Service(s) Offered
Figure 5.1 Company Competitiveness Analysis: Conjugation and Labeling Service Providers based in North America
Figure 5.2 Company Competitiveness Analysis: Conjugation and Labeling Service Providers based in Europe
Figure 5.3 Company Competitiveness Analysis: Conjugation and Labeling Service Providers based in Asia-Pacific
Figure 7.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2022
Figure 7.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 7.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 7.4 Partnerships and Collaborations: Distribution by Type of Partner
Figure 7.5 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Figure 7.6 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Figure 7.7 Partnerships and Collaborations: Distribution by Location of Headquarters of Partner
Figure 7.8 Partnerships and Collaborations: Distribution by Type of Partnership and Location of Headquarters of Partner
Figure 7.9 Most Active Players: Distribution by Number of Partnerships
Figure 7.10 Partnerships and Collaborations: Distribution by Region
Figure 7.11 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 7.12 Partnerships and Collaborations: Local and International Agreements
Figure 8.1 Global Event Analysis: Cumulative Year-wise Trend, 2018-2022
Figure 8.2 Global Event Analysis: Distribution by Event Platform
Figure 8.3 Global Event Analysis: Distribution by Type of Event
Figure 8.4 Global Event Analysis: Distribution by Year and Type of Event
Figure 8.5 Global Event Analysis: Distribution by Location of Event
Figure 8.6 Word Cloud Analysis: Evolutionary Trends in Event Agenda / Key Focus Areas
Figure 8.7 Most Active Organizers: Distribution by Number of Events
Figure 8.8 Most Active Industry Players: Distribution by Number of Speakers
Figure 8.9 Most Active Non-Industry Players: Distribution by Number of Speakers
Figure 8.10 Seniority Level of Event Speakers: Distribution by Number of Speakers
Figure 8.11 Global Event Analysis: Geographical Mapping of Upcoming Events
Figure 9.1 Conjugation and Labeling Services: SWOT Analysis
Figure 9.2 SWOT Factors: Harvey Ball Analysis
Figure 10.1 Global Conjugation and Labeling Services Market, 2023-2035 (USD Million)
Figure 10.2 Conjugation and Labeling Services Market: Distribution by Type of Molecule, 2023 and 2035
Figure 10.3 Conjugation and Labeling Services Market for Proteins, 2023-2035 (USD Million)
Figure 10.4 Conjugation and Labeling Services Market for Antibodies, 2023-2035 (USD Million)
Figure 10.5 Conjugation and Labeling Services Market for Peptides, 2023-2035 (USD Million)
Figure 10.6 Conjugation and Labeling Services Market for Small Molecules, 2023-2035 (USD Million)
Figure 10.7 Conjugation and Labeling Services Market for Other Molecules, 2023-2035 (USD Million)
Figure 10.8 Conjugation and Labeling Services Market: Distribution by Type of Molecular Conjugate / Label, 2023 and 2035
Figure 10.9 Conjugation and Labeling Services Market for Polymers, 2023-2035 (USD Million)
Figure 10.10 Conjugation and Labeling Services Market for Haptens, 2023-2035 (USD Million)
Figure 10.11 Conjugation and Labeling Services Market for Enzymes, 2023-2035 (USD Million)
Figure 10.12 Conjugation and Labeling Services Market for Fluorescent Tags, 2023-2035 (USD Million)
Figure 10.13 Conjugation and Labeling Services Market for Bead Coupling / Particle Conjugates, 2023-2035 (USD Million)
Figure 10.14 Conjugation and Labeling Services Market for Quantum Dots, 2023-2035 (USD Million)
Figure 10.15 Conjugation and Labeling Services Market for Isotopes, 2023-2035 (USD Million)
Figure 10.16 Conjugation and Labeling Services Market for Other Molecular Conjugates / Labels, 2023-2035 (USD Million)
Figure 10.17 Conjugation and Labeling Services Market: Distribution by Key Geographical Regions, 2023 and 2035
Figure 10.18 Conjugation and Labeling Services Market in North America, 2023-2035 (USD Million)
Figure 10.19 Conjugation and Labeling Services Market in Europe, 2023-2035 (USD Million)
Figure 10.20 Conjugation and Labeling Services Market in Asia-Pacific, 2023-2035 (USD Million)
Figure 10.21 Conjugation and Labeling Services Market in Middle East and North Africa, 2023-2035 (USD Million)
Figure 10.22 Conjugation and Labeling Services Market in Latin America, 2023-2035 (USD Million)
Figure 11.1 Concluding Remarks: Overall Market Landscape
Figure 11.2 Concluding Remarks: Partnerships and Collaborations
Figure 11.3 Concluding Remarks: Global Event Analysis
Figure 11.4 Concluding Remarks: Market Forecast and Opportunity Analysis
Table 4.1 Conjugation and Labeling Service Providers: List of Companies
Table 4.2 Conjugation and Labeling Service Providers: Information on Type of Molecule(s) Conjugated / Labeled
Table 4.3 Conjugation and Labeling Service Providers: Information on Type of Molecular Conjugate(s) / Label(s) Used
Table 4.4 Conjugation and Labeling Service Providers: Information on Type of Enzyme(s) Used
Table 4.5 Conjugation and Labeling Service Providers: Information on Type of Hapten(s) Used
Table 4.6 Conjugation and Labeling Service Providers: Information on Conjugation Service(s) Offered
Table 6.1 Conjugation and Labeling Service Providers: List of Companies Profiled
Table 6.2 AltaBioscience: Company Overview
Table 6.3 AltaBioscience: Recent Developments and Future Outlook
Table 6.4 Bachem: Company Overview
Table 6.5 Bachem: Recent Developments and Future Outlook
Table 6.6 Bio-Synthesis: Company Overview
Table 6.7 Cayman Chemical: Company Overview
Table 6.8 Cayman Chemical: Recent Developments and Future Outlook
Table 6.9 CliniSciences: Company Overview
Table 6.10 CliniSciences: Recent Developments and Future Outlook
Table 6.11 Eurogentec: Company Overview
Table 6.12 Eurogentec: Recent Developments and Future Outlook
Table 6.13 GBI: Company Overview
Table 6.14 GBI: Recent Developments and Future Outlook
Table 6.15 Mimotopes: Company Overview
Table 6.16 Mimotopes: Recent Developments and Future Outlook
Table 6.17 Peptide Institute: Company Overview
Table 6.18 Peptide Institute: Recent Developments and Future Outlook
Table 6.19 piCHEM: Company Overview
Table 7.1 Partnerships and Collaborations: Information on Year of Agreement, Type of Partnership and Type of Partner, 2018-2022
Table 7.2 Partnerships and Collaborations: Information on Type of Agreement (Country-wise and Continent-wise), 2018-2022
Table 8.1 List of Global Events related to Conjugation and Labeling of Biomolecules
Table 13.1 Conjugation and Labeling Service Providers: Distribution by Year of Establishment
Table 13.2 Conjugation and Labeling Service Providers: Distribution by Company Size
Table 13.3 Conjugation and Labeling Service Providers: Distribution by Location of Headquarters
Table 13.4 Conjugation and Labeling Service Providers: Distribution by Company Size and Location of Headquarters
Table 13.5 Conjugation and Labeling Service Providers: Distribution by Type of Molecule(s) Conjugated / Labeled
Table 13.6 Conjugation and Labeling Service Providers: Distribution by Type of Molecular Conjugate(s) / Label(s) Used
Table 13.7 Conjugation and Labeling Service Providers: Distribution by Type of Enzyme(s) Used
Table 13.8 Conjugation and Labeling Service Providers: Distribution by Type of Hapten(s) Used
Table 13.9 Conjugation and Labeling Service Providers: Distribution by Conjugation Service(s) Offered
Table 13.10 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2022
Table 13.11 Partnerships and Collaborations: Distribution by Type of Partnership
Table 13.12 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 13.13 Partnerships and Collaborations: Distribution by Type of Partner
Table 13.14 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Table 13.15 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Table 13.16 Partnerships and Collaborations: Distribution by Location of Headquarters of Partner
Table 13.17 Partnerships and Collaborations: Distribution by Type of Partnership and Location of Headquarters of Partner
Table 13.18 Most Active Players: Distribution by Number of Partnerships
Table 13.19 Partnerships and Collaborations: Distribution by Region
Table 13.20 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 13.21 Partnerships and Collaborations: Local and International Agreements
Table 13.22 Global Event Analysis: Cumulative Year-wise Trend, 2018-2022
Table 13.23 Global Event Analysis: Distribution by Event Platform
Table 13.24 Global Event Analysis: Distribution by Type of Event
Table 13.25 Global Event Analysis: Distribution by Year and Type of Event
Table 13.26 Global Event Analysis: Distribution by Location of Event
Table 13.27 Most Active Organizers: Distribution by Number of Events
Table 13.28 Most Active Industry Players: Distribution by Number of Speakers
Table 13.29 Most Active Non-Industry Players: Distribution by Number of Speakers
Table 13.30 Seniority Level of Event Speakers: Distribution by Number of Speakers
Table 13.31 Global Conjugation and Labeling Services Market, 2023-2035 (USD Million)
Table 13.32 Conjugation and Labeling Services Market: Distribution by Type of Molecule, 2023 and 2035
Table 13.33 Conjugation and Labeling Services Market for Proteins, 2023-2035 (USD Million)
Table 13.34 Conjugation and Labeling Services Market for Antibodies, 2023-2035 (USD Million)
Table 13.35 Conjugation and Labeling Services Market for Peptides, 2023-2035 (USD Million)
Table 13.36 Conjugation and Labeling Services Market for Small Molecules, 2023-2035 (USD Million)
Table 13.37 Conjugation and Labeling Services Market for Other Molecules, 2023-2035 (USD Million)
Table 13.38 Conjugation and Labeling Services Market: Distribution by Type of Molecular Conjugate / Label, 2023 and 2035
Table 13.39 Conjugation and Labeling Services Market for Polymers, 2023-2035 (USD Million)
Table 13.40 Conjugation and Labeling Services Market for Haptens, 2023-2035 (USD Million)
Table 13.41 Conjugation and Labeling Services Market for Enzymes, 2023-2035 (USD Million)
Table 13.42 Conjugation and Labeling Services Market for Fluorescent Tags, 2023-2035 (USD Million)
Table 13.43 Conjugation and Labeling Services Market for Bead Coupling / Particle Conjugates, 2023-2035 (USD Million)
Table 13.44 Conjugation and Labeling Services Market for Quantum Dots, 2023-2035 (USD Million)
Table 13.45 Conjugation and Labeling Services Market for Isotopes, 2023-2035 (USD Million)
Table 13.46 Conjugation and Labeling Services Market for Other Molecular Conjugates / Labels, 2023-2035 (USD Million)
Table 13.47 Conjugation and Labeling Services Market: Distribution by Key Geographical Regions, 2023 and 2035
Table 13.48 Conjugation and Labeling Services Market in North America, 2023-2035 (USD Million)
Table 13.49 Conjugation and Labeling Services Market in Europe, 2023-2035 (USD Million)
Table 13.50 Conjugation and Labeling Services Market in Asia-Pacific, 2023-2035 (USD Million)
Table 13.51 Conjugation and Labeling Services Market in Middle East and North Africa, 2023-2035 (USD Million)
Table 13.52 Conjugation and Labeling Services Market in Latin America, 2023-2035 (USD Million)
The following companies / institutes / government bodies and organizations have been mentioned in this report:
Source 1: https://experiments.springernature.com/articles/10.1007/978-1-0716-1186-9_35
PRICING DETAILS
Discounts available for multiple report purchases
sales@rootsanalysis.com
YOU MAY ALSO LIKE
SUBSCRIBE TO INDUSTRY UPDATES